José E. Teixeira

A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box

Rajiv S. Jumani, Kovi Bessoff, Melissa S. Love et al. · Antimicrobial Agents and Chemotherapy · 2018 · 68 citations · Full text

Pharmacy, Infectious Diseases, Pharmacology +17

A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors

Rajiv S. Jumani, Muhammad M. Hasan, Erin E. Stebbins et al. · Nature Communications · 2019 · 50 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of Infection

Muhammad M. Hasan, Erin E. Stebbins, Robert K. M. Choy et al. · Antimicrobial Agents and Chemotherapy · 2021 · 32 citations · Full text

Veterinary Medicine, Infectious Diseases, Veterinary Microbiology +17

Optimization of the Urea Linker of Triazolopyridazine MMV665917 Results in a New Anticryptosporidial Lead with Improved Potency and Predicted hERG Safety Margin

Edmund Oboh, Tanner J. Schubert, José E. Teixeira et al. · Journal of Medicinal Chemistry · 2021 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Expression of complement system regulatory molecules in the endometrium of normal ovulatory and hyperstimulated women correlate with menstrual cycle phase

Rosana Rita Nogawa Fonzar-Marana, Rui Alberto Ferriani, Sandro G. Soares et al. · Fertility and Sterility · 2006 · 19 citations · Full text

Life Sciences, Gynecology, Immunology +17